In a newborn with perioral cyanosis and a systolic blood pressure gradient between the upper and lower extremities, what is the best next step in management?

Immediate IV Prostaglandin Infusion

In a newborn presenting with perioral cyanosis and differential blood pressure between upper and lower extremities, the best next step is IV prostaglandin E1 infusion (Answer C) to maintain ductal patency while establishing the definitive diagnosis.

Clinical Reasoning

This presentation is classic for coarctation of the aorta with ductal-dependent systemic blood flow:

• Perioral cyanosis indicates inadequate systemic oxygenation
• Blood pressure gradient (higher in upper extremities, lower in lower extremities) suggests obstruction at the aortic isthmus level
• The patent ductus arteriosus (PDA) is currently providing blood flow to the lower body, but as it begins to close naturally, lower extremity perfusion deteriorates

Why Prostaglandin First

Prostaglandin E1 infusion is the critical stabilizing intervention that prevents cardiovascular collapse by:

• Maintaining or reopening the ductus arteriosus
• Restoring systemic perfusion to the lower body
• Preventing end-organ damage (kidneys, intestines, lower extremities)
• Providing time for complete diagnostic evaluation with echocardiography
• Stabilizing the patient before definitive surgical repair

Why Not the Other Options

Surgical repair (A) is the definitive treatment but should not be performed emergently without:

• Complete anatomic assessment via echocardiography
• Hemodynamic stabilization
• Evaluation for associated cardiac anomalies (present in 50-70% of CoA cases)
• Medical optimization to reduce surgical risk 1

Atrial septoplasty (B) is not indicated for coarctation of the aorta. This intervention is relevant for lesions requiring improved atrial-level mixing (like certain forms of transposition), not for aortic obstruction.

Follow-up (D) is dangerous and inappropriate. Without prostaglandin support, ductal closure will progress, leading to:

• Acute cardiovascular collapse
• Metabolic acidosis
• Renal failure
• Mesenteric ischemia
• Death

Diagnostic Confirmation

While initiating prostaglandin, obtain:

• Four-extremity blood pressures: Systolic gradient ≥20 mmHg between arms and legs confirms significant coarctation 2
• Echocardiography: Suprasternal notch view demonstrates the coarctation site, measures gradient, and identifies associated lesions
• Assessment of femoral pulses: Delayed or absent compared to brachial pulses

Important Caveats

In healthy newborns, unlike older children, lower extremity blood pressures are NOT normally higher than upper extremities 3. Therefore, any significant gradient favoring the upper extremities is pathologic.

Differential cyanosis patterns matter:

• Standard differential cyanosis (more cyanotic in lower body) suggests coarctation with PDA
• Reversed differential cyanosis (more cyanotic in upper body) suggests alternative diagnoses like supracardiac TAPVC 4

Subsequent Management Algorithm

1. Immediate: Start prostaglandin E1 (0.01-0.1 mcg/kg/min)
2. Within hours: Complete echocardiographic evaluation
3. Stabilization phase: Optimize metabolic status, correct acidosis, support end-organ function
4. Definitive repair: Surgical correction once stabilized, typically via thoracotomy with extended end-to-end anastomosis for isolated coarctation 1

The key principle: Prostaglandin buys time and prevents catastrophe while you establish the complete diagnosis and plan definitive therapy.